The European Union has given its approval for a higher dose of Novo Nordisk's popular weight-loss medication, Wegovy.

Politicians are proposing bans on pharmaceutical companies advertising directly to consumers, sparking a renewed debate about the ethics and impact of such marketing practices.

A Korean doctor issues a public warning about fraudulent 'oral Wegovy' weight loss supplements, advising consumers that these products are 100% scams.